Article Details
Retrieved on: 2025-05-02 13:18:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Novartis's acquisition of Regulus Therapeutics, emphasizing the role of Greek founders and venture capital investors in expanding RNA technology innovations. It highlights the significance of the venture capital fund, Kos Biotechnology Partners, in supporting Greek biotech ventures.
Article found on: en.protothema.gr
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here